School of Physiology, Pharmacology and Neuroscience, Biomedical Sciences Building, University of Bristol, Bristol, BS8 1TD, UK.
Wolfson BioimagingFacility, Biomedical Sciences Building, University of Bristol, Bristol, BS8 1TD, UK.
Nat Commun. 2023 Jul 7;14(1):4026. doi: 10.1038/s41467-023-39598-9.
Platelets, small hemostatic blood cells, are derived from megakaryocytes. Both bone marrow and lung are principal sites of thrombopoiesis although underlying mechanisms remain unclear. Outside the body, however, our ability to generate large number of functional platelets is poor. Here we show that perfusion of megakaryocytes ex vivo through the mouse lung vasculature generates substantial platelet numbers, up to 3000 per megakaryocyte. Despite their large size, megakaryocytes are able repeatedly to passage through the lung vasculature, leading to enucleation and subsequent platelet generation intravascularly. Using ex vivo lung and an in vitro microfluidic chamber we determine how oxygenation, ventilation, healthy pulmonary endothelium and the microvascular structure support thrombopoiesis. We also show a critical role for the actin regulator Tropomyosin 4 in the final steps of platelet formation in lung vasculature. This work reveals the mechanisms of thrombopoiesis in lung vasculature and informs approaches to large-scale generation of platelets.
血小板是一种小型止血血细胞,来源于巨核细胞。骨髓和肺部都是生成血小板的主要部位,但其潜在机制尚不清楚。然而,在体外,我们生成大量功能血小板的能力很差。在这里,我们展示了通过小鼠肺部脉管系统对巨核细胞进行体外灌注可以生成大量血小板,每个巨核细胞可生成多达 3000 个血小板。尽管巨核细胞体积庞大,但它们能够反复通过肺部脉管系统,导致去核并随后在血管内生成血小板。我们使用体外肺和体外微流控室来确定氧合、通气、健康的肺内皮细胞和微血管结构如何支持血小板生成。我们还表明,肌动蛋白调节蛋白 Tropomyosin 4 在肺部脉管系统中血小板形成的最后步骤中起着关键作用。这项工作揭示了肺部脉管系统中血小板生成的机制,并为大规模生成血小板提供了方法。